PHK
Point72 Hong Kong Portfolio holdings
AUM
$1.44B
1-Year Return
47.42%
This Quarter Return
-4.02%
1 Year Return
+47.42%
3 Year Return
+223.1%
5 Year Return
+307.89%
10 Year Return
+1,071.81%
AUM
$1.66B
AUM Growth
+$118M
(+7.7%)
Cap. Flow
+$183M
Cap. Flow
% of AUM
11%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
2,070
New
635
Increased
379
Reduced
339
Closed
696
Top Buys
| 1 |
Comcast
CMCSA
|
+$21.8M |
| 2 |
NextEra Energy, Inc.
NEE
|
+$21.5M |
| 3 |
S&P Global
SPGI
|
+$18.4M |
| 4 |
Marathon Petroleum
MPC
|
+$18M |
| 5 |
Alibaba
BABA
|
+$17.4M |
Top Sells
| 1 |
Yum China
YUMC
|
+$17.8M |
| 2 |
CVS Health
CVS
|
+$15.2M |
| 3 |
Marvell Technology
MRVL
|
+$15M |
| 4 |
Schlumberger
SLB
|
+$14.6M |
| 5 |
Diamondback Energy
FANG
|
+$14M |
Sector Composition
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 14.49% |
| 3 | Healthcare | 12.27% |
| 4 | Financials | 12.22% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Dime Community Bancshares
DCOM
$1.36B
| $62K | ﹤0.01% |
+2,126
| New | +$62K |
|
852
First Interstate BancSystem
FIBK
$3.41B
| $62K | ﹤0.01% |
1,544
-3,399
| -69% | -$136K |
|
853
Titan International
TWI
$558M
| $62K | ﹤0.01% |
5,096
+4,821
| +1,753% | +$58.7K |
|
854
Intellia Therapeutics
NTLA
$1.23B
| $61K | ﹤0.01% |
+1,097
| New | +$61K |
|
855
Ball Corp
BALL
$13.9B
| $61K | ﹤0.01% |
1,269
-5,166
| -80% | -$248K |
|
856
Monarch Casino & Resort
MCRI
$1.91B
| $61K | ﹤0.01% |
+1,093
| New | +$61K |
|
857
Organogenesis Holdings
ORGO
$639M
| $61K | ﹤0.01% |
18,699
+12,684
| +211% | +$41.4K |
|
858
Semtech
SMTC
$5.29B
| $61K | ﹤0.01% |
2,076
+976
| +89% | +$28.7K |
|
859
Genuine Parts
GPC
$19.9B
| $60K | ﹤0.01% |
401
-3,405
| -89% | -$509K |
|
860
InvenTrust Properties
IVT
$2.32B
| $60K | ﹤0.01% |
+2,790
| New | +$60K |
|
861
Viavi Solutions
VIAV
$2.74B
| $60K | ﹤0.01% |
4,628
-15,768
| -77% | -$204K |
|
862
Coca-Cola Consolidated
COKE
$10.8B
| $60K | ﹤0.01% |
1,450
-2,360
| -62% | -$97.7K |
|
863
ESAB
ESAB
$6.86B
| $59K | ﹤0.01% |
+1,763
| New | +$59K |
|
864
Goldman Sachs
GS
$238B
| $59K | ﹤0.01% |
+201
| New | +$59K |
|
865
HCI Group
HCI
$2.36B
| $59K | ﹤0.01% |
1,511
+977
| +183% | +$38.1K |
|
866
Ligand Pharmaceuticals
LGND
$3.26B
| $59K | ﹤0.01% |
+1,090
| New | +$59K |
|
867
Pebblebrook Hotel Trust
PEB
$1.4B
| $59K | ﹤0.01% |
4,041
-10,429
| -72% | -$152K |
|
868
Zentalis Pharmaceuticals
ZNTL
$113M
| $59K | ﹤0.01% |
+2,740
| New | +$59K |
|
|
PRMW
869
DELISTED
Primo Water Corporation
PRMW
| $59K | ﹤0.01% |
+4,674
| New | +$59K |
|
|
ICPT
870
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $59K | ﹤0.01% |
+4,215
| New | +$59K |
|
871
AtriCure
ATRC
$1.87B
| $58K | ﹤0.01% |
1,489
-173
| -10% | -$6.74K |
|
872
HNI Corp
HNI
$2.11B
| $58K | ﹤0.01% |
2,197
-363
| -14% | -$9.58K |
|
873
Oil States International
OIS
$348M
| $58K | ﹤0.01% |
14,786
+7,149
| +94% | +$28K |
|
874
Sana Biotechnology
SANA
$875M
| $58K | ﹤0.01% |
+9,733
| New | +$58K |
|
875
Sylvamo
SLVM
$1.77B
| $58K | ﹤0.01% |
1,722
-2,551
| -60% | -$85.9K |
|